The treatment of Cataracts & Sinusitis with vitamins

Cataracts and Sinusitis: Mitamins custom make quality formulas for the treatment of Cataracts & Sinusitis with vitamins. A Cataracts & Sinusitis formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cataracts and Sinusitis

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    Riboflavin
    75
    mg
    4412%
    Selenium
    200
    mcg
    286%
    Alpha Lipoic Acid
    50
    mg
    *
    Lutein
    6000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
    Garlic Extract
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
  • Amount Per Serving
    % DV
    Grape Seed Extract
    25
    mg
    *
    N-Acetyl L-Cysteine
    50
    mg
    *
    Turmeric Extract
    50
    mg
    *
    Oregano Extract
    50
    mg
    *
    Goldenseal Extract
    50
    mg
    *
    Grapefruit Extract
    50
    mg
    *
    Bromelain
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Cataracts and Sinusitis Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Second Lyme Infection Likely Means Two Tick Bite
People who experience a second episode of the characteristic Lyme disease bull's-eye rash likely were bitten by another tick, rather than experiencing a relapse of the first infection, suggests a preliminary study being presented at the 45th Annual Meeting of the Infectious Diseases Society of America (IDSA). The study is the first to evaluate molecular evidence of recurrent Lyme disease.
Survival Data In FDA Approval For ERBITUX® (Cetuximab) Supports Use As A Single Agent In Patients With Advanced Colorectal Cancer
ImClone Systems Incorporated (NASDAQ: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has approved an update to the ERBITUX® (Cetuximab) product labeling to include overall survival data as a single agent in epidermal growth factor inhibitor (EGFR)-expressing metastatic colorectal cancer (mCRC) patients after failure of both irinotecan- and oxaliplatin-based regimens.
This information concerning the support of Cataracts and Sinusitis treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments